U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H19NO3
Molecular Weight 321.3698
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ACRONINE

SMILES

COC1=CC2=C(C=CC(C)(C)O2)C3=C1C(=O)C4=C(C=CC=C4)N3C

InChI

InChIKey=SMPZPKRDRQOOHT-UHFFFAOYSA-N
InChI=1S/C20H19NO3/c1-20(2)10-9-13-15(24-20)11-16(23-4)17-18(13)21(3)14-8-6-5-7-12(14)19(17)22/h5-11H,1-4H3

HIDE SMILES / InChI
Acronine is an acridone alkaloid isolated from the bark of Acronychia bauri Schott, scrub ash indigenous to Australia. It possesses broad-spectrum activity against experimental neoplasms. Acronine has been studied in the treatment of multiple myeloma. Acronine analogues also possess cytotoxic and antitumor activity.

Approval Year

PubMed

PubMed

TitleDatePubMed
The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.
2010-08-01
Identification of thymidylate synthase as a potential therapeutic target for lung cancer.
2010-07-27
An unusual DNA binding compound, S23906, induces mitotic catastrophe in cultured human cells.
2010-03-28
Synthesis and cytotoxic activity of psorospermin and acronycine analogues in the 3-propyloxy-acridin-9(10H)-one and -benzo[b]acridin-125H-one series.
2010-02
Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
2009-12
Acronycine derivatives: a promising series of anticancer agents.
2009-09
4'-Chloro-3',5'-dimethoxy-acetanilide.
2009-04-22
[Effect of peroxisome proliferators activated receptor gamma and its ligand on airway mucus hypersecretion in rats].
2009-04
Antitumor psoropermum xanthones and sarcomelicope acridones: privileged structures implied in DNA alkylation.
2009-03-27
Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
2009-03-01
Fused xanthone derivatives as antiproliferative agents.
2009-01
Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
2008-12
Synthesis, cytotoxic activity, and mechanism of action of furo[2,3-c]acridin-6-one and benzo[b]furo[3,2-h]acridin-6-one analogues of psorospermin and acronycine.
2008-11-27
2,2-dimethyl-2H-pyran-derived alkaloids I. Practical synthesis of acronycine and benzo[b]acronycine and their biological properties.
2008-09
Synthesis and cytotoxic activity of dimeric analogs of acronycine in the benzo[b]pyrano[3,2-h]acridin-7-one series.
2007-05
[From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
2007-01
Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine.
2006-08
Generation of replication-dependent double-strand breaks by the novel N2-G-alkylator S23906-1.
2006-07-15
Synthesis, antitumor activity, and mechanism of action of benzo[a]pyrano[3,2-h]acridin-7-one analogues of acronycine.
2006-06-01
Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
2006-01
Synthesis and cytotoxic activity of acronycine analogues in the benzo[c]pyrano[3,2-h]acridin-7-one and naphtho[1,2-b][1,7] and [1,10]-phenanthrolin-7(14H)-one series.
2005-12
Design, synthesis, and cytotoxic activity of Michael acceptors and enol esters in the benzo[b]acronycine series.
2005-08
Antimalarial activity of thioacridone compounds related to the acronycine alkaloid.
2005-03-01
Synthesis, biological evaluation, and molecular modeling of novel thioacridone derivatives related to the anticancer alkaloid acronycine.
2005-02-01
[Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents].
2005-01
[Acronycine revisited: development of benzo[b]acronycine antitumor agents].
2005-01
Covalent binding of antitumor benzoacronycines to double-stranded DNA induces helix opening and the formation of single-stranded DNA: unique consequences of a novel DNA-bonding mechanism.
2005-01
Structure-activity relationship studies of new acronine analogues as suggested by molecular descriptors.
2005
Benzo[b]acronycine derivatives: a novel class of antitumor agents.
2004-08
Synthesis and cytotoxic activity of pyranocarbazole analogues of ellipticine and acronycine.
2004-05
Design of novel antitumor DNA alkylating agents: the benzacronycine series.
2004-03
Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
2004-03
A transesterification reaction is implicated in the covalent binding of benzo[b]acronycine anticancer agents with DNA and glutathion.
2004-01-02
Synthesis and cytotoxic activity of some new azapyranoxanthenone aminoderivatives.
2003-10-15
Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
2003-07-03
Covalent binding to glutathione of the DNA-alkylating antitumor agent, S23906-1.
2003-07
Synthesis of 6-dialkylaminoalkylamino pyrano[2,3-c]acridones and benzo[b]pyrano[3,2-h]acridones: soluble acronycine analogues with increased cytotoxic activity.
2003
Structure-activity relationships in the acronycine series.
2002-09
Alkylation of guanine in DNA by S23906-1, a novel potent antitumor compound derived from the plant alkaloid acronycine.
2002-08-06
[New antitumor agents in the acronycine series].
2002-07
Design, synthesis, and antiproliferative activity of some new pyrazole-fused amino derivatives of the pyranoxanthenone, pyranothioxanthenone, and pyranoacridone ring systems: a new class of cytotoxic agents.
2002-06-06
Design and synthesis of some new pyranoxanthenone aminoderivatives with cytotoxic activity.
2002-06-03
Acronycine derivatives as promising antitumor agents.
2002-06
Induction of apoptosis in HL-60 leukemia and B16 melanoma cells by the acronycine derivative S23906-1.
2002-04-15
Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis.
2001-12
Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-ones.
2001-11
1-Oxo-2-hydroxy-1,2-dihydroacronycine: a useful synthon in the acronycine series for the introduction of amino substituents at 6-position and for the conversion into isopropylfuroacridones.
2001-10
Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
1991-01-01
Anti-herpesvirus activity of citrusinine-I, a new acridone alkaloid, and related compounds.
1989-08
Screening for new compounds with antiherpes activity.
1984-10
Patents
Name Type Language
COMPOUND 42339
Preferred Name English
ACRONINE
HSDB   INN   USAN  
USAN   INN  
Official Name English
acronine [INN]
Common Name English
ACRONINE [HSDB]
Common Name English
COMPOUND-42339
Code English
NSC-403169
Code English
3,12-Dihydro-6-methoxy-3,3,12-trimethyl-7H-pyrano[2,3-c]acridin-7-one
Systematic Name English
ACRONINE [USAN]
Common Name English
7H-PYRANO(2,3-C)ACRIDIN-7-ONE, 3,12-DIHYDRO-6-METHOXY-3,3,12-TRIMETHYL-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C2163
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
Code System Code Type Description
NSC
403169
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
PUBCHEM
345512
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
WIKIPEDIA
Acronine
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
ChEMBL
CHEMBL285852
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
EPA CompTox
DTXSID0020026
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
INN
2670
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
CAS
7008-42-6
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
HSDB
7073
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
MESH
D000175
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
FDA UNII
QE0G097358
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
CHEBI
2437
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
SMS_ID
100000087694
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
EVMPD
SUB05254MIG
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY
NCI_THESAURUS
C75297
Created by admin on Mon Mar 31 18:01:23 GMT 2025 , Edited by admin on Mon Mar 31 18:01:23 GMT 2025
PRIMARY